Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to assess the performance of the Vivante Health GIMate Breathalyzer device in diagnosing lactose malabsorption.


Clinical Trial Description

Lactose malabsorption is a common condition due to lactase deficiency which results in gastrointestinal symptoms for many which is termed lactose intolerance. Lactase is an enzyme occurring in the intestinal mucosa that hydrolyzes lactose into its constituent parts, galactose and glucose. The enzyme is normally present in neonates, however, for a majority of individuals in the world there is an inherited and irreversible reduction in enzyme activity as individuals age. Secondary lactose malabsorption can also occur when there is injury to the intestinal mucosa from a reversible condition such as infection. The mechanism of hydrogen detection is based on undigested lactose in the colon being fermented by bacteria resulting in the production of hydrogen which is then partially absorbed into the bloodstream and ultimately exhaled by the lungs via the pulmonary circulation and gas exchange. Direct lactase activity can also be measured on tissue obtained through jejunal biopsy via endoscopy. This approach, however, is more invasive, costly, and potentially less reliable given issues relating to sampling bias Current clinical hydrogen breath tests for diagnosis of lactose malabsorption are bulky and expensive for clinical providers to use and obtain. As a result, Vivante Health is testing how effective the GIMate device is in diagnosing lactose malabsorption as an alternative option. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04754724
Study type Interventional
Source Vivante Health
Contact
Status Completed
Phase N/A
Start date April 1, 2021
Completion date August 1, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05100719 - The Role of Irritable Bowel Syndrome in Lactose Intolerance (LION) N/A
Completed NCT02518295 - β-galactosidase Producing Probiotic Strains to Improve Lactose Digestion N/A
Completed NCT00599859 - Effects of Lactose on Fecal Microflora N/A
Completed NCT02636413 - Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance Phase 4
Completed NCT02406469 - Effects Comparison of A1 and A2 Milk on Gastrointestinal Physiology, Symptoms and Cognitive Behavior Phase 4
Terminated NCT00247806 - Prevalence of Lactose Intolerance Following Stem Cell Transplantation Phase 1
Completed NCT03814668 - Effect of Probiotic Supplementation on Lactose Maldigestion Induced by Lactose Solution N/A
Completed NCT03860051 - Association Between Lactase Deficiency, and the Small Intestinal Microbiome in Adults.
Not yet recruiting NCT06107088 - Effect of a Combination of Lactase and L. Salivarius DSM 34078 in Individuals With Lactose Intolerance N/A
Completed NCT02703987 - HYBRID: Hydrogen Breath Test in Lactose Digestion N/A
Completed NCT00395954 - Amount of Lactose Causing Symptoms in Lactose Intolerant People Phase 0
Completed NCT01593800 - The Effect of Probiotics on Lactose Intolerance N/A
Completed NCT04164394 - Effect of I31 Probiotic on Lactose Intolerance N/A
Recruiting NCT05668468 - A Bifido Bacteria to Improve Lactose Digestion and Tolerance N/A
Completed NCT03563846 - Effect of a Standard Meal on the Pharmacokinetic Profile of RP-G28 in Healthy Adult Male and Female Subjects Phase 1
Recruiting NCT02085889 - Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders
Completed NCT03597516 - Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance Phase 3
Not yet recruiting NCT03563859 - Evaluation of Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance Phase 3
Completed NCT02171403 - Comparison of the Colonic Metabolism in Patients With Lactose Intolerance and Healthy Controls N/A
Completed NCT01145586 - A Non-inferiority, Multicenter and Randomized, Multiple-Dose Study About a Treatment to Hypolactasia Phase 3